Medicare Enrolled

Dr. Shiraz Yazdani, M.D.

Student in an Organized Health Care Education/Training Program · Lubbock, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
3419 22ND ST, Lubbock, TX 79410
8067963000
Registered in NPPES since 2009
NPI: 1093942484 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yazdani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yazdani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yazdani

Dr. Shiraz Yazdani is a student in an organized health care education/training program specialist in Lubbock, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Yazdani performed 5,386 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Yazdani received a total of $358,937 from 29 pharmaceutical and/or device companies across 869 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yazdani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years of NPI registration ▲ Top 3% volume in TX $358,937 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
5,386
Medicare services
Top 3% in TX for student in an organized health care education/training program
Not available
Unique patients (not deduplicated)
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
1,990 $0 $3
Contrast dye for imaging, lower concentration 1,200 $0 $2
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
269 $123 $909
Additional sacral spine nerve root injection with imaging
An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging.
139 $49 $272
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
138 $121 $481
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
138 $191 $199
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
131 $60 $65
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
105 $126 $968
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
102 $69 $493
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
99 $131 $425
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
87 $89 $315
New patient office visit, complex (60-74 min) 83 $157 $672
Spinal injection with imaging guidance
A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location.
79 $98 $718
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
77 $65 $213
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
73 $273 $2,389
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
73 $110 $983
Spinal neurostimulator electrode insertion
A procedure to place an electrode array into the spine through the skin. The electrode is used to deliver electrical stimulation to the nervous system.
68 $240 $3,838
Midazolam injection, per 1 mg
Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments.
68 $0 $5
Injection, fentanyl citrate, 0.1 mg 68 $1 $3
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
44 $103 $687
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
39 $120 $1,108
Facet joint injection, second level, with imaging
An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement.
38 $68 $540
Injection of anesthetic agent and/or steroid into other nerve or branch 37 $54 $425
Facet joint nerve destruction, single joint
This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint.
35 $305 $2,373
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint.
34 $156 $1,065
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
34 $44 $168
Sedation by physician, initial 15 minutes
Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older.
31 $38 $149
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
30 $52 $311
Spinal neurostimulator generator insertion
Surgical placement of a spinal neurostimulator generator or receiver device.
25 $171 $1,240
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
24 $80 $226
Spinal fracture stabilization with imaging guidance
A procedure to stabilize a broken bone in the middle spine by placing a device, using imaging guidance during the treatment.
17 $4,395 $14,714
Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones 11 $347 $1,321
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$358,937
Total received (2018-2024)
Avg $51,277/year across 7 years
Top 0% in TX for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
869
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$131,543
2023
$42,055
2022
$77,908
2021
$71,661
2020
$30,973
2019
$2,968
2018
$1,829

Payments by company (2024)

ABBVIE INC.
$111,985
Abbott Laboratories
$13,995
Medtronic, Inc.
$4,631
SI-BONE, INC.
$220
MML US, Inc.
$193
Curonix LLC
$181
Nevro Corp.
$158
Boston Scientific Corporation
$145
VERTEX PHARMACEUTICALS INCORPORATED
$20
PFIZER INC.
$14
Top 3 companies account for 99.3% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$184,125
AbbVie Inc.
$87,218
Allergan, Inc.
$42,527
Medtronic, Inc.
$18,039
Abbott Laboratories
$17,741
Medtronic USA, Inc.
$3,020
Vertiflex, Inc.
$1,553
Relievant Medsystems, Inc.
$1,526
BOSTON SCIENTIFIC CORPORATION
$655
SI-BONE, INC.
$516
Boston Scientific Corporation
$396
PFIZER INC.
$245
Nevro Corp.
$208
MML US, Inc.
$193
Curonix LLC
$181
SI-BONE, Inc.
$146
DePuy Synthes Sales Inc.
$136
Daiichi Sankyo Inc.
$120
Collegium Pharmaceutical, Inc.
$117
Stryker Corporation
$79
Merck Sharp & Dohme LLC
$51
Takeda Pharmaceuticals U.S.A., Inc.
$30
Spinal Simplicity, LLC
$27
VERTEX PHARMACEUTICALS INCORPORATED
$20
Horizon Therapeutics plc
$15
Teva Pharmaceuticals USA, Inc.
$13
Lundbeck LLC
$13
Allergan Inc.
$13
Assertio Therapeutics, Inc.
$12
Top 3 companies account for 87.4% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · ADAPTIVESTIM · AJOVY · AXIUM · Accurian · Amitiza · BOTOX · BOTOX THERAPEUTIC · BRIDION · ETERNA · Gralise · HA MINUTEMAN G3-R · IFUSE IMPLANT · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · LYRICA · MONOVISC · Morphabond ER · Movantik · NSE - CUTTING ACCESSORIES · NURTEC ODT · OCTRODE · OSTEOCOOL RF ABLATION · PEAK · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · QULIPTA · ReActiv8 · SUPERION · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · Superion · Superion ISS · Superion Indirect Decompression System · UBRELVY · VANTA ADAPTIVESTIM · VYEPTI · Vanta · XTAMPZA · iFuse Implant
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a student in an organized health care education/training program specialist in Lubbock?
Compare student in an organized health care education/training programs in the Lubbock area by procedure volume, costs, and industry payment transparency.
Browse student in an organized health care education/training programs nearby

Geographic Context

Student in an organized health care education/training programs in nearby ZIP areas
105
County median income
$63,367
Nearest hospital to ZIP centroid (approximate)
COVENANT MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yazdani is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Yazdani experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Yazdani performed 1,990 dexamethasone injection (steroid) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Yazdani receive payments from pharmaceutical companies?
Yes. Dr. Yazdani received a total of $358,937 from 29 companies across 869 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yazdani's costs compare to other student in an organized health care education/training programs in Lubbock?
Dr. Yazdani's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yazdani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →